On October 3, ImmuPharma plc informed that a Nomination Committee has been appointed to consist of the following persons who together represent 7.52% of the number of shares and votes in the company as of September 30, 2023: Sara Ek, Carl Borrebaeck and Mats Leifland, Sara Ek being appointed Chair of the nomination Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 GBX | 0.00% | -8.94% | +28.37% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.37% | 11.1M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IMM Stock
- News ImmuPharma plc
- ImmuPharma plc Announces Executive Appointments